Fujifilm presents integrated synapse portfolio to optimize workflow and improve patient care at ACC 2014

Stamford, Conn., March 27, 2014 - FUJIFILM Medical Systems U.S.A., Inc. will highlight an integrated Synapse portfolio that allows cardiologists and clinical professionals to enhance patient care through optimized productivity at the 63rd Annual Scientific Session & Expo of the American College of Cardiology (ACC) on March 29 - 31 in Washington, DC.

“Cardiology departments need solutions that will improve workflow. Fujifilm offers advanced features and exceptional images to accelerate workflow and enhance diagnostic confidence,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “With Synapse, our customers are able to perform their job more efficiently and ultimately allows them to concentrate more on the patient and improve overall patient outcomes.”

Following is a summary of offerings:

Synapse Cardiovascular helps cardiologists in a variety of clinical areas efficiently and confidently interpret exceptional images with streamlined workflow, image review and reporting. With full image management and reporting capabilities, and tools designed specifically for nuclear cardiology, vascular ultrasound, ECG management, echocardiography, cardiac catheterization, CT, and Cardiac MRI workflows, Fujifilm's Synapse Cardiovascular is an essential addition to any clinical workplace.

Cardiologists interested in advanced visualization and analysis will find the innovations of Fujifilm’s Synapse 3D very appealing for their diagnostic needs with twenty nine functions to choose from. It is fully integrated with Synapse PACS and Synapse Cardiovascular, and eliminates the need to access advanced diagnostic tools from a separate workstation or with a separate login. Patient lists are synchronized, making it up to date at all times.

Also to be introduced is Synapse Analytics, an advanced tool that provides critical, timely data to assist decisions made by healthcare professionals about clinical operations and financial performance. This is a single application for use across the Synapse PACs, RIS, and CV platforms and allows the user to build, manipulate, and monitor a full suite of Business Intelligence dashboards and reports.

To register for a product demonstration at ACC, please visit: http://www.fujimed.com/gateway/acc/2014/pacs.asp . For more information about Synapse, please visit: http://cardiovascular.fujimed.com/

About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 10 companies around the world granted U.S. patents in 2012, and in the year ended March 31, 2013, had global revenues of $26.7 billion*. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.

* At an exchange rate of 83 yen to the dollar.

 

 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."